Revolution Medicines, Inc.

RVMD

RVMDRevolution Medicines, Inc. US flag

NASDAQ Global Select

155.99

USD

+4.68

- -

33.16BMarket Cap

Income Statement (USD)

API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Sales/Revenue/Turnover	- -	20	50	43	29	35	12	- -	- -
+ Sales & Services Revenue	- -	20	50	43	29	35	12	- -	- -
- Cost of Revenue	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Profit	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Operating Income	- -	-20	-50	-43	-29	-35	-12	- -	- -
- Operating Expenses	31	60	104	154	217	294	499	690	1,182
+ Selling, General & Admin	5	9	12	21	30	41	76	97	195
+ Research & Development	27	51	92	132	187	253	423	592	987
+ Other Operating Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income (Loss)	-31	-40	-54	-111	-188	-258	-487	-690	-1,182
- Non-Operating (Income) Loss	- -	1	-2	-2	-1	-9	-47	-89	-51
+ Interest Expense, Net	- -	-1	-2	-2	-1	-9	-47	-87	-66
+ Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	24
- Interest Income	- -	1	2	2	1	9	47	87	91
+ Other Non-Op (Income) Loss	- -	2	- -	- -	- -	- -	- -	-2	15
Pretax Income	-31	-42	-52	-109	-187	-249	-440	-601	-1,131
- Income Tax Expense (Benefit)	- -	- -	-4	- -	- -	- -	-4	-1	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	-31	-42	-48	-108	-187	-249	-436	-600	-1,131
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -	- -	- -	- -	- -	- -
Income (Loss) Incl. MI	-31	-42	-48	-108	-187	-249	-436	-600	-1,131
- Minority Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income, GAAP	-31	-42	-48	-108	-187	-249	-436	-600	-1,131
- Preferred Dividends	4	7	14	2	- -	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-35	-49	-62	-110	-187	-249	-436	-600	-1,131
EBIT	-31	-40	-54	-111	-188	-258	-487	-690	-1,182
EBITDA	-30	-39	-51	-104	-181	-249	-478	-678	-1,166
EBITDA Margin (%)	- -	-191.25	-101.47	-242.31	-614.75	-702.72	-4,126.74	- -	- -
EBITA	-31	-40	-54	-111	-188	-258	-487	-690	-1,182
Gross Margin (%)	- -	100	100	100	100	100	100	- -	- -
Operating Margin (%)	- -	-200	-108.15	-257.54	-639.7	-730.01	-4,207.12	- -	- -
Profit Margin (%)	- -	-207.24	-95.25	-251.63	-636.58	-702.95	-3,768.28	- -	- -
Sales per Employee	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Depreciation Expense	1	2	3	7	7	10	9	12	17
Basic Weighted Avg Shares	36	36	53	55	73	81	113	168	190
Basic EPS, GAAP	-0.96	-1.34	-1.17	-2.01	-2.57	-3.08	-3.86	-3.58	-5.95
Basic EPS from Cont Ops	-0.85	-1.15	-0.9	-1.97	-2.57	-3.08	-3.86	-3.58	-5.95
Diluted Weighted Avg Shares	36	36	53	55	73	81	113	168	190
Diluted EPS, GAAP	-0.96	-1.34	-1.17	-2.01	-2.57	-3.08	-3.86	-3.58	-5.95
Diluted EPS from Cont Ops	-0.85	-1.15	-0.9	-1.97	-2.57	-3.08	-3.86	-3.58	-5.95

Balance Sheet (USD)

API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Current Assets	9	85	134	454	590	660	1,879	2,328	2,075
+ Cash, Cash Equivalents & STI	9	70	123	441	577	645	1,853	2,289	2,026
+ Cash & Cash Equivalents	9	70	17	104	108	161	696	543	384
+ ST Investments	- -	- -	106	336	469	484	1,157	1,746	1,642
+ Accounts & Notes Receiv	- -	7	9	6	6	5	1	- -	- -
+ Accounts Receivable, Net	- -	7	9	6	6	5	1	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other ST Assets	- -	9	2	7	7	11	25	38	49
+ Misc ST Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Noncurrent Assets	6	85	87	113	148	152	182	231	279
+ Property, Plant & Equip, Net	5	7	7	36	71	74	100	142	165
+ Property, Plant & Equip	7	10	13	44	82	88	118	164	194
- Accumulated Depreciation	2	4	6	8	11	14	18	22	29
+ LT Investments & Receivables	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other LT Assets	- -	78	79	77	77	78	82	89	114
+ Total Intangible Assets	- -	78	77	76	74	73	72	71	70
+ Goodwill	- -	15	15	15	15	15	15	15	15
+ Other Intangible Assets	- -	63	62	61	60	59	58	57	56
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Assets	- -	1	3	1	2	5	10	18	44
Total Assets	15	171	221	567	738	812	2,062	2,558	2,355
+ Payables & Accruals	5	8	20	24	32	37	109	120	208
+ Accounts Payable	3	5	11	13	14	21	62	54	65
+ Accrued Taxes	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Payables & Accruals	2	2	9	11	18	16	47	65	143
+ ST Debt	- -	- -	- -	4	6	7	7	13	16
+ ST Borrowings	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Finance Leases	- -	- -	- -	4	6	7	7	13	16
+ Other ST Liabilities	3	23	23	20	23	18	28	31	66
+ Deferred Revenue	- -	17	17	12	12	4	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc ST Liabilities	3	6	6	8	10	14	28	31	66
Total Current Liabilities	8	31	43	47	60	62	144	164	290
+ LT Debt	- -	- -	- -	29	60	57	81	123	142
+ LT Borrowings	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Finance Leases	- -	- -	- -	29	60	57	81	123	142
+ Other LT Liabilities	3	43	25	17	15	7	11	6	291
+ Accrued Liabilities	3	43	24	16	14	7	3	2	2
+ Pension Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Liabilities	- -	1	1	1	1	- -	8	4	288
Total Noncurrent Liabilities	3	43	25	46	75	65	92	129	433
Total Liabilities	11	74	68	93	135	127	236	293	723
+ Preferred Equity and Hybrid Capital	72	205	305	- -	- -	- -	- -	- -	- -
+ Share Capital & APIC	- -	1	5	740	1,056	1,388	2,963	4,002	4,497
+ Common Stock	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Additional Paid in Capital	- -	1	5	740	1,056	1,388	2,963	4,002	4,497
- Treasury Stock	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Retained Earnings	-68	-110	-157	-266	-453	-701	-1,138	-1,738	-2,869
+ Other Equity	- -	- -	- -	- -	- -	-2	1	1	3
Equity Before Minority Interest	5	97	153	475	603	685	1,826	2,265	1,631
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Equity	5	97	153	475	603	685	1,826	2,265	1,631
Total Liabilities & Equity	15	171	221	567	738	812	2,062	2,558	2,355
Shares Outstanding	53	53	53	67	74	90	165	186	197
Number of Employees	- -	- -	- -	- -	- -	- -	- -	- -	- -
Capital Leases - Total	- -	- -	- -	33	67	64	88	136	159
Net Debt	-9	-70	-17	-104	-108	-161	-696	-543	-384
Net Debt to Equity	-200.38	-71.99	-10.92	-21.97	-18.01	-23.56	-38.12	-23.97	-23.52
Tangible Common Equity Ratio	-449.14	-200.34	-159.26	81.15	79.59	82.84	88.16	88.21	68.34
Current Ratio	1.24	2.8	3.11	9.63	9.77	10.65	13.06	14.2	7.14
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -

Cash Flow Statement (USD)

API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
+ Net Income	-31	-42	-48	-108	-187	-249	-436	-600	-1,131
+ Depreciation & Amortization	1	2	3	7	7	10	9	12	17
+ Non-Cash Items	- -	3	4	10	24	28	40	30	130
+ Stock-Based Compensation	- -	1	3	9	21	31	62	79	118
+ Deferred Income Taxes	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Non-Cash Adj	- -	2	- -	1	3	-3	-22	-49	12
+ Chg in Non-Cash Work Cap	5	38	-9	-8	9	-13	37	- -	87
+ (Inc) Dec in Accts Receiv	- -	-7	-1	2	- -	1	3	1	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	1	-1	-1	-2	- -	-4	-5	-17	-22
+ Inc (Dec) in Accts Payable	4	2	11	5	11	9	47	16	122
+ Inc (Dec) in Other	- -	44	-18	-14	-3	-20	-9	1	-13
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Operating Activities	-25	1	-50	-100	-147	-224	-351	-557	-898
+ Change in Fixed & Intang	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Acq of Fixed & Intang	-2	-1	-3	-3	-7	-11	-8	-10	-16
+ Acq of Fixed Prod Assets	-2	-1	-3	-3	-7	-11	-8	-10	-16
+ Acq of Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	- -	- -	420	291	298	386	846	348
+ Increase in Capital Stock	- -	- -	- -	420	291	298	386	846	348
+ Decrease in Capital Stock	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Change in LT Investment	- -	- -	-106	-231	-136	-13	-335	-544	134
+ Dec in LT Investment	- -	- -	67	313	536	599	724	1,593	1,929
+ Inc in LT Investment	- -	- -	-172	-544	-671	-613	-1,059	-2,137	-1,795
+ Net Cash From Acq & Div	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	6	- -	- -	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Investing Activities	-2	-1	-102	-234	-142	-24	-343	-554	118
+ Dividends Paid	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Cash From Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash From Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Repayments of Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Financing Activities	23	61	99	3	3	3	843	113	274
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Financing Activities	23	61	99	423	294	301	1,229	959	622
Effect of Foreign Exchange Rates	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Changes in Cash	-4	61	-53	88	5	53	536	-152	-158
EBITDA	-30	-39	-51	-104	-181	-249	-478	-678	-1,166
EBITDA Margin (%)	- -	-191.25	-101.47	-242.31	-614.75	-702.72	-4,126.74	- -	- -
Free Cash Flow	-27	- -	-52	-103	-154	-235	-358	-568	-914
Net Cash Paid for Acquisitions	- -	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow to Equity	- -	126	34	-410	-154	-235	-358	-568	-914
Free Cash Flow per Basic Share	-0.73	-0.01	-0.99	-1.88	-2.11	-2.92	-3.17	-3.38	-4.81
Price/Free Cash Flow	- -	- -	- -	-22.37	-13.03	-8.99	-9.47	-13.41	-17.17
Cash Flow to Net Income	0.81	-0.03	1.04	0.93	0.79	0.9	0.8	0.93	0.79
Capital Expenditures	-2	-1	-3	-3	-7	-11	-8	-10	-16